¸qeuê24 Bulletin of Social Medicine, No.24 2006àÙćòÈPZAQ,fý+y;cµõ¦

A survey of attitudes and knowledge for drivers with dementia
þěóĊ1), ÆöîĮ¬1), ĀvĶ1), Đ ¢2), ·«čÒ3)1) ćòÈp¾éėJ_K2) ĦiéuÍĝĵ{ďJ_K3) ÖĶq .UHSK[Tomoyuki Watanabe1), Yoko Konagaya1), Kazuhiro Fujikake1), Masaru Miyao2) and Hiroto Shibayama3)
1) Obu dementia care research and training center, Japan.
2) Information technology center, Nagoya University, Japan.
3) Asahigaoka hospital, Japan.
C^

P: ćòÈĴ¹fýPZAR_EGVY\

K

Key words: dementia, elderly people, driving, driving simulator-5+&ćòÈPZAQĈĴ¹PZAQ÷²ám;*),â*ám((6+º¸q++8;fýz';(~xú+Ďï;½Ğ#'*fý>ô¯"+³Ĵk¸q

Ăº9÷|y*),èç÷½ð0,dİ3¡$&Ð"*Īë×&;³Ăº8/+2=<;>ā;(Áĭ';

Ă|Ė³ýº,°ğ²,ê 1 ÿ²¹(*$"fý¹

!'Ġ'-ĆÌ,fýÎ,àÓ+Ú5; 65 ¨bË,w¡-1994 Ĉ+ 9.1%'
$"10 Ĉ, 2004 Ĉ+- 15.7%(Ĉ&;(ćòÈPZAQ+y;ÄĪë+%&,ćµ>ħ9+;(ám>ĩú(&?_F

1)

2"2003 Ĉ+-Ü¤, 65 ¨bË,fý

O+8;cµõ¦,o+%&Â1;

ĨÉĜĬ¹- 870 ġÒ>g65 ¨bË,©ìĴ
¹,ćòÈĬĔı>ī 4-6(;(35 ġÒbË,ĴPZAQ+ćòÈ,nċÔ;+ćòÈPZAQ

2)ćòÈPZAQ,8+y;cµõ¦A +¿4fýĨÉ>ĜĬ©6fý>&,ám+8$&Áé*²,;Ì¹>æÊ+ĆÌ,fýÎ

7ćòÈPZAám*),ĪëÑ£k;ĉ;§'-QćòÈPZAQęÕ 18 Ĉ 9 +¶®ªm,ăcą"9<+y;ĪësXN@?'D]+y;?_FOõ¦>$"?_F

O-

I?LT<;8+*:Īër+"¼:Ý

"¹+æ&ä±ÛíĪë+8;ĥ}Ħ?_FO>

3Ĥ(*$&;

³}´+&¶®"*Ġ'-ĈĴ>30 ¨*9fý+đĭ*ćò|ċ,øj>³t

ģĢ

»ĈÞ 


30-64 ¨ôĈÞ 65 ¨bË

+fý>ã&;Ĵ¹-ßÿÓ;+6y=ĴÞ , 3 %+Ęĳ"æÊ¹-ñÔ 82 Ħ

9!<>Č`;GHMWaÜ­Ą,üù

30 ¨ģĢ27 Ħ30-64 ¨30 Ħ65 ¨bË25

8/fýô¯,ûØ*æh-2#ĕÀĘ';2Ħ ÅÔ 53 Ħ

30 ¨ģĢ11 Ħ30-64 ¨37 Ħ"ćòÈPZAQ

65 ¨bË5 Ħ, 135 Ħ':ęĈĴ,fýċĲ,ēl½Ğ+y;ÏįÔåÿÔ,BRN_H6Ç*"$

Ě¥



-ñÔ45.2

19.1¨ÅÔ44.4

ĒÃ
15.1

TKXga 24 rBulletin of Social Medicine, No.24 2006
v"



5I:

'¸®3m#/*5) ¬AG7B@"(­Ã¶'\»ª'&}&-0ziR!0#3!*

Àp¿ 1) M¤(%º#x*2) J#

6) ¬'(s.¾c3/10#3²)!M¤_&$'.·P/*3)

M¤"%#«Z&t/*4) M¤¾c!* 7)AG7CI9; EFH
Driving Simulator: JO DS 3>!*

 1

M¤(%º#x*
1. x2. x3. */x2%4. x2%
2. J#²)!M¤_&$'.·P/*1.
_ Á2. Á3.  4.  
5. ·2.%
3. M¤"%#«Z&t/*
1. t02. t03. */t.%4. t.%
4. M¤¾c'¸®3m#/*
1. 02. 03. */%4. %
5. ¬AG7B &-0ziR!0#3 !*
1.  !02.  !03. */.%4. .%
6. ¬'(s.¾c3/10#3 !*
1.  !02.  !03. */.%4. .%7.
AG7CI9;EFH >3 !*1.  !02.  !03. */.%4. .%
8. 70 vJ'º(¾cl{&M¤£fu3~y0qÃo `¼´.1!
0#3 !*
1.  !02.  !03. */.%4. .%
9. qÃo "(AG7CI9;EFH > 3w !M¤£fu3n#3!*
1.  !02.  !03. */.%4. .%10. AG7CI9;EFH > "M¤¯Â3£&³Q"0#x*
1. x2. x3. */x2%4. x2%
11. ¬]¯?<@"|¨'M¤'S±3£&³Q"0#x*
1. x2. x3. */x2%4. x2%1.

12. |¨'M¤3,+0 ($4%#"? µU§S
1. ;EFH > ,¬]¯?<@&-0M¤¯Â³Q"°¡1#
2. kdj ][~1# ¥B<%$'58=<Mn»%$
3. ¾c3¸®&0kdj ]['MYL¦"#
4. ¹e'b¦"#
5. zi3^#
6. W{&DGI?65&-0N.10#7. V¢&¾c'j´h10¦"#
8. ®©'½3#
9. ,+0#("%
10. '

B0,174M24;Bulletin of Social Medicine, No.24 2006

 2
A[:Z1) -OHCV?

30 >XW

?

3(7.9%)

?

9(23.7%)



1
8
8

#?%

?%

T.

2

(5.3%)

H

6(15.8%)

1
4
1
4
3
8



T%"
 <6
3) -O

#(5.3%)

\

EH

6
7(100.0%)

2



1
0
1
9
3
1
7

(21.1%)

2) +KS-O3D"\

30-64 >

(47.4%)

3
8

 <6

(%)



1

1
1
3
4
6
7

(36.8%)(100.0%)PIJ2=#  2(55.3%)
1

7(28.4%)(46.3%)(10.4%)(100.0%)

1
5
6(36.8%)(14.9%)

65 >+H

<6(23.3%)

20 (14.8%)

1
0
1
2
1

(33.3%)

38 (28.1%)(40.0%)

61 (45.2%)(3.3%)

16 (11.9%)

30(100.0%)135(100.0%)4(13.3%)

7(5.2%)(53.3%)

33 (24.4%)(0.0%)

12 (8.9%)



(1.5%)(9.0%)

1
6
0(16.4%)

1(3.3%)

26 (19.3%)(50.7%)

9(30.0%)

57 (42.2%)(100.0%)3
0(100.0%)135(70.1%)

2
7(90.0%)

95 (70.4%)(23.9%)

3(10.0%)

28 (20.7%)(4.5%)

0(0.0%)

8(5.9%)(22.4%)(100.0%)=$

9(23.7%)

5(13.2%)

4
7
1
6
3

="

3

(7.9%)

1(1.5%)

0(0.0%)

4(3.0%)<63
8(100.0%)6
7(100.0%)3
0(100.0%)135(100.0%)



#

$

0

(0.0%)

0(0.0%)

2(6.7%)

2(1.5%)

$1(2.6%)

1(1.5%)

2(6.7%)

4(3.0%)

2(5.3%)

4(6.0%)

3(10.0%)

9(6.7%)(76.7%)

120(88.9%)(100.0%)135(100.0%)=$#="4) -OY5GUR&9

#

3
5
3
8


 <6

5) QNF(*')!$@8N$

N


#N"

N"
<6

$

(92.1%)(100.0%)L/

8(21.1%)

8(21.1%)

1
0
1
2
3
8

(26.3%)(31.6%)(100.0%)





6
2
6
7

2
3
3
0

(92.5%)(100.0%)$&N
3(55.2%)
71(14.9%)
01(14.9%)
01(14.9%)
06(100.0%)
7






2
(73.3%)
2

67 (49.6%)

4(13.3%)

22 (16.3%)

3(10.0%)

23 (17.0%)

1(3.3%)

23 (17.0%)

30(100.0%)135(100.0%)





24

Bulletin of Social Medicine, No.24 2006s 28E;>mWNIgh(%)()!
]|S{

 Xxw



X

XFe

UM

qlc/g0V2zLd7`3b$54#,7l'*1&l'*4 

   

 

&#%l'*4 

  



  

 



  

 13l2-
l2-











 





xJp





 













 UM

 





 

 


?C9@E:<ABD=7l'*1&
l'*4





 





&#%l'*4 

   



13l2- 

 





 





 l2-  

UM



  XFe/v0zLPf\.GoniOW7^[&4T~_Ral'*1&
l'*4





 

&#%l'*4 

13l2- 

 l2-  

 UM








 

     


Kyu"25*4#,7

 





  

  

   



   

 







T~_Ra+0?C9@E:<ABD=7Y'*GonjOW7Q#,7l'*1&l'*4 



&#%l'*4 

  

  

 

 l2- 

  

 

UM







13l2-  
  

 
    



?C9@E:<ABD=+Gor}7nk.tH+!4,Z1&Z    

&#%Z   

13Z6-





 



 Z6-  



 UM



     

     

  

  

 

yKEP`W24kBulletin of Social Medicine, No.24 2006

 2
w»iº



(%)

30-64 n65 nD

30 nµ´11) ¦S©:8;!u¤{'G¡'J«2
q

1

q

1
5
1
6
6

).q1$
q1$

3
8

l^

(2.6%)(39.5%)(42.1%)(15.8%)

%­I!/"q)
1(43.3%)
6 (9.0%)3
13(33.3%)(50.7%)
0
4
2(29.9%)
4 (13.3%)07 (10.4%)
3 (10.0%)67(100.0%)3
0(100.0%)12) u¤{'G¡2+*/(#3$"!? ¯L£J
7?@B 9 +¦S©:8;%,/G¡©¼­I!ª0"
dZcSRx0
"
¹Y 2±¨%
/dZcSR'G
QF¢!"
²\'~X¢!
"
sb2T"l^20(14.8%)

59(43.7%)

40(29.6%)

16(11.9%)(100.0%)135(100.0%)*1
1(28.9%)

3
2(47.8%)

1
5(50.0%)

58(43.3%)

17(44.7%)

2
4(35.8%)

7(23.3%)

48(35.8%)

1
0(26.3%)

1
6(23.9%)

2(6.7%)

28(20.9%)

3(7.9%)

7(10.4%)

0(0.0%)

10(7.5%)

1
8(47.4%)

2
5(37.3%)

1
0(33.3%)

53(39.6%)

7(18.4%)

7(10.4%)

0(0.0%)

14(10.4%)

Nt%>AC:54%,/H~-0/"M%¹Y 'c®a0/¢!
"¨¥'¸2~"

6(15.8%)

1
7(25.4%)

1
4(46.7%)

37(27.6%)

1
4(36.8%)

3
1(46.3%)

1
0(33.3%)

55(41.0%)+*/"(!$4(10.5%)

7(10.4%)

5(16.7%)

16(11.9%)

1(2.6%)

3(4.5%)

5(16.7%)

9(6.7%) '* (%)(O§½]°' 30 nµ´38 30-64 n67 65 nD30 l^135 

%

/Ql
8)

70 nD'³(¹Y

et%G¡

xr/j½zhV¶®-0"!

/"2)9) j½zh!(DS 2p
_m2g"2

_m2

¯L£J

["¦<A6=

G¡

%

%

¬ 1 G¡'»%/¦v

¬ 2

fo

)10) DS !G¡©

¼2

%­I!/"q)11) ¦S©:1) G¡(}$³"q)

8;¦'U/#2­I/:8G¡}"q;&!u¤{'G¡'J«2

%­I!/"q

/(|§§!(

%*/Ql(§!()12) u¤{'G¡2+*/(#3$


·

14.9%



q

19 ·

q

10

28.4%

"L

¤\Odo× 23 Bulletin of Social Medicine, No.23 2005
í$ÀÍÓ/úÁ.ċ$-/.Ôę¥ÎºÇf¸*0úÁK¸

9Üćêā;1iā.«7À/ćÒ+

10 Ď



7 Ď

²
/ñß

Ć9>+< 2), 7)5!0¡ï¦/RéB-ĘwĘ°ø)9ėgtB=¡ï¦.ÕA>Nï©Ú/Æ

*'$ęHJDI

33.3%.()0¿ÓçÇĕçl÷
Ę-,



23.3%

/ãTBk8Òcç.î?)=R

é.þē+?>ôÛl÷

ýaąB>+þē*>

ñ.ÞMĘxiÅĘĐØ]}Ę-, .()9Wę.ù')ãT
Ré.9Suüº.>+^í$Àêā;=3)-6)>+<?>

4) Réďpµ/ĄöB$+=5§õ,/õÕ94+C,/ÀRéďpµ/ĄöBÝõÎ;=9ęÎ/ćRé.¡½>ÀÒ$+ -+^í$ 30 čċ35 Ď 92.1% y.=?0Ré{á$8*>+

30-64 čċ62 Ď 92.5% 65 K¸23 Ď 76.7% <?>Ý*9ęÎ*ĄöB$+
6.7%



>

2 Ď

>

6.7%

2 Ď

+^í

2) KÌ+û3)Rém®.,/<ăU=5$À0A!*=¡Ă*Ré*>i0ď$pµ/Ąö0)-ÀÒ1998 õ 4 ~.ď§õÝõÎ*0KÌ+û3)Rém® Ĕ&$pĄöÃëÃä?À/¾È.;=RéďpĔ&$+^í$À/e0±'$
ęÎ*0

Ĕ&$

4 Ď

$

53.3%

+^í$ÀÍÓ/úÁK¸

16 Ď

13.3% >+X÷+-'$ 8), 9)ìq

µBĄö

Ĕ&

ê/ 48 ĊÀBÔ¶+$à*0ďpµBĄö$ę¥0 257 À* 0.5%.

-+'$Ć9

*'$QćÌ¯/ 1) Ré0¸©-ć%+=/ĈĖ*0ę¥/ďpµ.jA>Ô+

5)/£Ä0ã+<?> 10)/Đ.0ęÎ*Ré¸©-ć%+^í)>ÀÒ£.Rém®Ĕ&$

Ĕ&$+^í$ę¥/&¢Đ 1)*
Ré¸©%+



À0"?#? 5 Ď5) ôÛ´HJDI+^í$

25% 7 ĎÛ')5=3 eæ

.;>ÏW)>+BęÎ*0Û')>+^í$ÀÖāĂBë/ę¥0KÌ;=0Rém®Ĕ&$+¡bB

Ë8$

73.3%

)>9//5%Ré.0¡½>+')>>ÀđúÁ*=+6<?>"/$8Ré÷ĘBnhç.ÿV

035%©Ú.;')/Ré÷ĘB¡b>>+þē

22 Ď

QćÝõÎ*0
37 Ď

55.2%

Û')

§õÎ*

Û')>À9k8)9úÁKT.

-'$

16 Ď

42.2%

[



?5*.£

11)*=èÊ-Ré÷ĘÿVX÷- DS :ôÛl÷$ðĒ/à

FEG-,/_ø¬ē+->

^í$À0²-/à<đ 1 õ{Z$*9§õÝõÎ*0Û')>+^/à.)94,ăU-'$3) Ré*-+óºÇf.=5ôÛ´/À/Ré.j0>»Ćår:zøfïB<ęÎ*04+C,/ÀRé*-+óºÇ.Évç.£ę¥K`/ÂÕ.9Û')9<f.

þē@5$ôÛ´HJDI

>+^í

27 Ď

90.0%

§õÝõ

/ĐØ0ĉ

Î*9Ré*-+óºÇf.·­>+^í

À%*0-YÐ:ª=/À$&/ĕ]9þē*$ÀúÁK¸*'$ 30 čċ21 Ď 55.3% =/;-MČ*9Ò/À¼BÛ>+30-64 47 Ď¬ē*> 12)70.1%

õę.A<!¡ï¦0óºÇf.þēĀX|*>+)>ÀÒ
¡ï¦/RéB

.:8>+0ò+<?

6) ôÛ´/À0<ďpµB¨=³?>+B>ñ.sâljøÙ)-ÜP.«7Û')5À.+')¡ï¦K`/Nï©Ú²-+ó§õÝõÎ*0ºÇf.>¡ï¦2/LÑB8)>+<?>£¡ï¦/Ré*--'$¹.ó


Û<-

63.2% 30-64 29 Ď

43.3%

30 čċ24 Ď


5=Û<

- 30 čċ3 Ď 7.9% 30-64 12 Ď 17.9%

­eYl{Þ24Bulletin of Social Medicine, No.24 2006
ÉÝąć>Ñ3'9ġÓ(4ėþË
+

11 ē

20.0%

36.7



19á8+)gð"d-;1(-å'4Ò¸- 5) ÷á¼MQBN

á8|ĉĘ®-ÆÏ,7:]îĔ|½-¨±ĈùÌïé

6 ē38;òø 108)

875 V¿>ġ®¶-´Ù¾®)'«¡'"2001 ø-ôĢæ,,7:¤Õ

čhÎ,792002 ø 6

870 V¿,\b':)>á$'1-ªĖ)òě,×^'«¡;:7,+$"

13)

-É

Ù¾®- 65 V¿-ã(4á8+)gð"

á8+)gð"2002 ø 6æčhÎ,7$'

UW[e.âĊ¼-ôĢ

É°oē""3;8Ù¾)+:ġ®/-÷á¼µá4Āĝ(:p®-]îĔ|½>è¢:.²9»)(:7,+$"

Ďå-1), 13))>á:veº+)

8;÷á¼MQBN9) ġ®¶(.DS >$']îíÎ>

-¤-«Û4s3"Âċ

ê}-Á>Õ5)÷á¼MQBN)>á$'1/-rÄ,

:-(.+#<*-7+t¹

°øãøÓ(.þËV¿(÷á¼MQBNď19 ē

>ýé*-7+Ăa³č(]îã¢>ýà:-)$"Øì+;'+-Ã(914)-17)

á8+

50.0% 30-64 27 ē

40.3%

30 đ




19á8+ 30 đď9 ē 23.7% 30-64 

È.§

18 ē

-ñcß)+)gð"ġÓ(4þË

26.9%

á8+

$':

+

5ē

9 ē

30.0%

:.

19á8

16.7%

)gð"ġÓ(4 70 V¿>Ù¾)"ġ®¶zĒ&8;':

7) DS >á$'1á$':).á$':!-öĚ,%'.19á8;)gð"É.þËV¿ 30 đď26 ē 68.5% '+7(:ġ®¶(.~Ď5£äj

30-64 39 ē~+*>nĜ"¶-Ö«y¶)' DS ,

*-øÜ4

á$':

58.2% 65 V¿17 ē

56.6%($"Ďå(.«- DS -¬Ç>ê§'

7:ªĖ""3DS )ēÒ#(.=8+$'~¶Áö-E"É4¬Ç>'Ğf"ÉÕ"-(.+)îíÎúĠ>Ăa:))+$':"#

=;:DS .ÔĆ+*R@RLA,:"-¶.-)<]î

3DS >Ĝ"]îúĠĂa-,Ĥ5Xģq]î>ã¢

Ý+$"9=6:!-"3Ã(.0)?*-÷á¼MQBN

FOPT

H

Ê)

=;:wćăğ>x5+9íÐ,]îú
Ġ>Ăa(+Á4·':úĠĂa-K18)]îíÍ>«¡"9ýé[òÀG>«¯(]î:),7$']ó±+ĕì($':)>ĕì)"4-(.+ 18)Ĕ|½>Å':)=;'9õ,÷á¼MQ
BN

!-"3]î

,r:Ĕ|½-]Ĝ.-cß(: 8)

S-Z%)' DS >')

1";8ġ®¶>´:),+:øġ-4$) DS >Ø(:ve>Õ5³,]îú

É,Ù'4ġ®¶-zĒ_)¤«#(

Ġ>ICJD(: DS >iü:Āĝ<.+!-öĚ,%'4Âċê}'Āĝ:8) 70 V¿-Č.Ĕ|Å¦,]îíÍ>«¡:ġ®¶zĒĄ8;':)>á$'10) DS (]îúĠ>íÐ,Ăa(:)11

*-øÜ4 )gð"É.ºË($" 30 ġ ® Ó ( . Ý ą ć 90.0%

á$':

27 ē)gð"øÜ°+:,%;'

8+)gð:É-mÝē

31.6% 30-64 10 ē

ē

3.3%

đď2 ē

áV¿7 ē

30 đď12

14.9% 65 V¿1

°øãøÓ-÷áïçĞę-Z%

5.3% 30-64 5 ē

23.3% 

7.5% 65 É4 3

5 mëï9 30 đď10 ē 26.3% 30-64 
35 ē

52.2% 65 V¿14 ēîúĠĂa-K

46.7% DS >]S)'`8-uÚ>¥$':)'ġ®¶,Ù'«Đ+rÄû

Éÿkì×28;";1(-{(.ġ)8;:d(.1998 ø 4®¶(Ĝ8;':]îíÎ

79Ĕ



ôĢā©LG©bTjwÞ 23 Bulletin of Social Medicine, No.23 2005
D3 DS ;ħ!XöąĮsąĎ]Ę&7 HDS-R+×*´ĩ+Ăä

7',ā&7!1DS 3ĂäsąCAD)(

dòëáÌ¦nRäąĎ];Ï0:%Óó*Ď]7@ACI;è7

A>

L CDR (Clinical Dementia Rating Scale)?N

GJ

B½&+ğİ)(+ĂäsąCAD)(ħ'ČĨ&9

58eg&,¨«;ħ!İ½;#!Ė2
719)-27)

Ăä»EK=F

12) ¥ü«+Xö;317#,(<)'&+XöąĮ;ôÉ*Ď@HJM]&!`ó)®Ę,058)#!/!DS;ħ!Ď]®Ę2û8%7đÃcú28), 29)B

3ĂäsąCAD&XöąĮćï

8!''cú!ÂØ058!

´ĩ+ DS30 ě&,ÿ*ø+Ăä»+Â*Û%XöąĮ+íZ;Ě11 ĝ30-64 32 ĝ65 P½15 ĝ ×*¶&)'7DS *47`5£;,zìso²¨8!'tqÅ;ĤÖ7¡č)Ăä»+W§

ĝ30-64 24 ĝ65 P½7 ĝ £;t

m*4#%Ď]r·;Êï7ČĨ7)(+ġß

!'

6

29)

¤÷&,Ăä»EK=F

30 ěĚ1730 ěĚ18 ĝ30-64 25 ĝ65;¶&7

P½10 ĝ Ąþ+ËĞ;°!' 30XöąĮĎ]®Ę,hĬ8%)5*DSěĚ14 ĝ30-64 31 ĝ65 P½10 ĝ,ÿ¯)ÔçČĨ&ÆĊħ6mª*)

'cú!ÂØ#!įÐ&,ãfó*Ġ0)¨«'ĉi%Ò*)(+ġß

x¼+ďÄ87Äø&!''cú

7¨«46OÎ&6Ĕª×+«3õ!Â+k×+ăįÐ'ĉi%Ø|*#!

)(+ìÀ{;¥ģ*Êï&7'ī÷27

30 ěĚ6 ĝ30-64 17 ĝ65 P½14 ĝ 

30)

ÎÚó*DS 3ĂäsąCAD*47Ď]&Xö;DS +`+0&Ăä»EK=F

317(+ćâ;!'%7ÂØ+XöôÈ;ô+ÁĪÅÙùÅ+Ď]¡č+hĬÜ!87/İ½XöĎ];ôÈ*',À&,ā&7!zìso²¨8-¥ü«*Ý:7Sü®

!1¨+İ½Xö46nē) DS +ėXöôÈã'%īħ!'%72Ø058ÿ*

É*Ď]&7:&,)Ăä»EK=F

/!įª±+uĜ[&zìsoĆà%)åU&+ÛvĜ&7įªÕ7'ĤÑ87'

7¨*£;t%5Xö;31+Ď]*Ģħ&7
DS ;~

31)

7';7Â2Ø£;tÍ*Xö;35¸ĩó*, DS *47Ď]2Ģħ&9

17'āÀĐê6')#!5*11) ĂäsąCAD&¥ü«+Xö+_Ĉ;ôÉ*ĎĂä»+Â,\*Ëþ;°%Xö;317';Ą

]&7'þ!'%2//!,

+'¥Ú;ę8%/!1Ëþ7',ā+!1Ăä»EK=F

'cú!Â+k.

,įÐ&Ø|*7 30 ěĚ16 ĝ 42.1% +ËĞ;p1!ÛY3ĂäsąíZ7Í5X

30-64 40 ĝ 59.7% 65 P½23 ĝ 76.6% ö+qÅ3Xö;31!+ÛY*$%+ËĞ¬ăéăÐ&/6:)';û7ČĨ9/!ãfó*XöĠx¼

30 ěĚ22 ĝ+ď¿Ä874)Äø;û7)(cú!Â 4:)

5 kñø!

ĘÇċ2µĨaß&7

57.9% 30-64 27 ĝ 40.3% !"¬ăéăÐ&,ĂäsąCAD;°74)sb¹)
CAD+Āĥ;4ä5)_ąÅ27!1

/'1ĂäsąCAD+Āĥ;ä#!&Xö+_Ĉ;ô

Ăä»EK=F

É*Ď]&)'įª±+uĜ[3Â,2#'¹)+&,)Ăä»

'0587ĂäsąCAD,7ñø¥ü«*47£+Õ^70 P½+
+ĀĥOQVb,æĕ»mª+XöĠx¼;î¢7,­6ºXö+_Ĉ+ćâĭ'%Ģ&7'%7

'&74*)#!)(*$%³Ē*ÂØ'587DS 'ýĦ*ĂäsąCA

,ä58%)ÀĞ5*)#!,Ă

D+0&Ăä»EK=F

ä»+Â+Xö*o7Ħ+XöôÈ;ôÉ*Ď]

)¾Ėðy}Ćlü;Þwe|¨Ę24½Bulletin of Social Medicine, No.24 2006
Ô. 2005: 134; 450-453.

ŗ³»')+Ōų*=;.ľ*
0Q`WúřÇÔDaN
S^DV8) ôďĨÿ}İËÃŊŞĐ. ģşv­.

TOR-,*Ľğñ=ú/Ŭę.()â<ô;>=+ČŬęģşĀS^DV+qč/v­Ŕ))<ù¼3')+Ē>=

Ě.(). Žľąýe|ÇÔ. 2004: 15; 102-1103%Ľğñ/ÿ/jį/pň/ŅĜë/ 1 (+9) ºfŰŊËúfũļĺ. ¼Żß2/®ĪbĉđÅ

)¹;=jįŁŸAŎo!=Ĭ-Îō03Ľğñ¼Żß/jįAĤù+&zŵ>);"DS 7ĽğŁ¥Â-,AŲÇÔ. 2005: 107(12); 1335-1343%±sĬ-ŎoP

_/yńŧ*=%&). ąýý

|10) úyòĻ·ě¯Ğ. ¬¼Żß/bĉ. ŝ¤/r

Ĺ.¼Żß7tĊĠ.çB*=ÿ-,ĖĔdķãĝ

|. 1999: 41; 336-342

Ũ©*=+@'))6ØķáAjį#11) ıŜġŀĶ}ſ³ŉ¿Đ. ¼Żß/jį÷=Aĸ-õ¾6=%5Øķá.Ė@=®Īã

+ĽğñS^DVĝ/èÜŌų*<»Ă-,/żÏkőp

2006: 4295; 81-84.!=¨. ļŦeÕúŠ.

¢+-?Á¬0qčeŷ»Ă¡Æ12) ŭďŊĈ¶ÝäÜţİ8<Đ. ģş¼Żß

Ġg-,ż!=+.:')Ľğñ/ÿ/¦ŴØķájįAĜĿ!=qī~qčđì+K`aZ

AĎé

~.ąýý

((jįAĤÐ

$/¬/Ą/IYR|ÇÔ. 2005: 107(12); 1344-1347

65%ċ¾Ĭ-JLQ\AÄ=+éų*<13) ďÊİö²ūnŴŋ. Ūµú.Ŧ¸/ħÂ£s0$/hî+-=6/+¹;>==ŬęŢĬ-+65). Žľąýe|ÇÔ.

Ŧ¸A3+5=.%<Ľğñv­¨¨åė

2005: 16; 802-808

œMaNźūŶËÑ:1CaG%&%xű.ù;àR.Ÿ

14) û ĩŶ . ¼ Żß +® Īb ĉ. Žľ ąý e| ÇÔ .

%

2002: 13(3); 252-253.

 -   Ŧ ¸ .   = ħ Â 0  Ś ā 17  18
ľ ĳ Žÿŝ¤¤´ČþĵÕ.:=¨Õ15) Ģİ|. ģşĀ¼Żß+Øķájį. Žľąýe|ĲÌ

ŕ.=Ľğñ¼Żß/jįŁŸŎo.!=¨/h+)»@>%

ÇÔ. 2003: 14(4); 404-405
16) ôďĨÿ}İËnÖø×Đ. ģşĀŽÿ+ØķájįuÀ.=ģşĀŽÿ/jįŬę2/đm. Źïąýe|. 2002: 31(3); 313-321
É¹Ř§17) ôďĨÿ}İËťď8<. ģşĀÛ+Ø1) ¡ÒĦś. Śā 17 ľņ ¡ÆŃí. ĴÙwÞķájį

9#2005

qč/đm/Üē.(). łý2) Ģİ|ţİĕ²Ňøſ. ģşñß/Øķá|ÇÔ. 2005: 107(12); 1348-1352

16; 815-821
19) ÈďƀÈŐĆŖ

functioning. Clin Geriatric Med 1993: 9; 365-375
4) Retchin SM, Anapolle J. An overview of the older driver.

æŒ. ¼Żß/jįŁŸ+Õª. Žľąýe|ÇÔ. 2003: 14(4); 413-423
20) ðŦ¯lĢİ|ţİĕ²ĐS^DWaFJ

Clin Geriatr Med 1993: 9; 279-296
5) ėļš«žś. ¼ŻßjįĭăUaSXOE. ĴØķáêw2005[]`NAŲ%C_PUDZŏß/jį

ŁŸŎo/Ó4. Žľąýe|ÇÔ. 2005: 16; 1326) ÈiŴóćðhü. ¼Żß/ĽğŁÒ{Ĭĥců±ÒŭAĤù+18) ðŦ¯lţİĕ²Ģİ|. ¼Żß/jį/Ü
ē+Á¬/ĮŤ.(). Žľąýe|ÇÔ. 2005:

3) Colsher PL, Wallace RB. Geriatric assessment and driverÞ. 2005: 57(5);409-414jįĤÐ.!=HaMaIL+eÍ/Ů~.(). ąýý

ļŦ.=ģşß/Øķájį+). Žľąýe|ÇÔ.

2005: 16(7); 785-791

21) Rizzo M, Reinach S, McGhee D, et al. Simulated car
crashes and crash predictors in drivers with Alzheimer
disease. Arch Neurol 1997: 54 (5); 545-551

7) ţİĕ²Ģİ|İŜ. ĠšĲÌ.=¼

22) Hunt LA, Murphy CF, Carr D, et al. Reliability of theŻß/Øķájį+°®Ī.!=cÚ

Washington University road test -A performance-based

ģş+Øķájį/ŬęAĤù.. ļŦeÍwÇ

assessment for drivers with dementia of the Alzheimerg:/=OD 23 WBulletin of Social Medicine, No.23 200510) >zst9µe^fe^Bytype-. Arch Neurol 1997: 54 (6); 707-712
23) Rizzo M, McGehee DV, Dawson JD, et al. Simulated

20m]2003;159-169

Car Crashes at Intersections in Drivers With Alzheimer11) Amagasa T., Nakayama T., Takahashi Y, Karojisatsu in

Disease. Alzheimer Dis Assoc Disord 2001: 15 (1); 10-

Japan: Characteristics of 22 cases of work-related

20

suicide. J Occup Health. 2005; 47(2): 157-164

24) Ott BR, Heindel WC, Whelihan WM, et al. Maze test{

performance and reported driving ability in early
dementia. J Geriatr Psychiatry Neurol 2003: 16(3); 151-13) st9µa~xr<µ\Tk

14) VGq­n25) Wild K, Cotrell V. Identifying driving impairment in
Alzheimer disease: A comparison of self and observerreports versus driving evaluation. Alzheimer Dis Assoc

26) Duchek JM, Carr DB, Hunt L, et al. Longitudinal
driving performance in early-stage dmentia of the
Alzheimer type. J Am Geriatr Soc

2003: 51(10); 1342-

134727) Uc EY, Rizzo M, Anderson SW, et al. Driver routefollowing and safety errors in early Alzheimer disease.
Neurology 2004: 63 (5); 832-837
28) =§Uo©S4. "*%.
')-°¥p@h1³¡

6. j8=XODcH¥{V´hei1N±¯RAOD¤| 16 ?O

D¦Ym. 2005; 37-41
29) o©S4=§U. ,¢1³5A$&+#.M["*%.')-°

1³¡

. ¶~x/=_b. 2006: 17; 977-98530) «vd. V´¥p@hei1Z;

1999; P.17IPlª. ~xxK=_b.

2005: 107(12); 1322-1327
31) `¸. V´h1³¡6. ¶~x/=_b.
2005: 16; 792-801e^®¨&#),E15) !),(CF¬e^·171-344T£Q1985

Disord 2003: 17(1); 27-34

Lw²82003;7(4):298-303

3}Tk3}2000;64(2):106-112

155

6

12) st9µe^fuJ®¨7